Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.70 |
| ▸ | TSHR | P16473 | 2/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | MARS2 | Q96GW9 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | RPLP1 | P05386 | 1/20 | 0.60 |
| ▸ | RPLP0 | P05388 | 1/20 | 0.60 |
| ▸ | RPS17 | P08708 | 1/20 | 0.60 |
| ▸ | RPSA | P08865 | 1/20 | 0.60 |
| ▸ | RPS2 | P15880 | 1/20 | 0.60 |
| ▸ | RPL35A | P18077 | 1/20 | 0.60 |
| ▸ | RPL7 | P18124 | 1/20 | 0.60 |
| ▸ | RPL17 | P18621 | 1/20 | 0.60 |
| ▸ | RPS4Y1 | P22090 | 1/20 | 0.60 |
| ▸ | RPS3 | P23396 | 1/20 | 0.60 |
| ▸ | RPS12 | P25398 | 1/20 | 0.60 |
| ▸ | RPL13 | P26373 | 1/20 | 0.60 |
| ▸ | RPL10 | P27635 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12413849 | 0.86 | LMNA (0.71) | LMNATSHRSMN1; SMN2CYP3A4ALDH1A1 | |
| Cetophenicol SCHEMBL192096 | 0.85 | LMNA (0.67) | LMNATSHRSMN1; SMN2CYP3A4ALDH1A1 | |
| Cetophenicol SCHEMBL192097 | 0.85 | LMNA (0.67) | LMNATSHRSMN1; SMN2CYP3A4ALDH1A1 | |
| SCHEMBL29651721 | 0.84 | LMNA (0.66) | LMNATSHRSMN1; SMN2CYP3A4ALDH1A1 | |
| SCHEMBL10777805 | 0.84 | LMNA (0.66) | LMNATSHRSMN1; SMN2CYP3A4ALDH1A1 | |
| SCHEMBL9836784 | 0.84 | ALDH1A1 (0.65) | LMNATSHRSMN1; SMN2CYP3A4ALDH1A1 | |
| SCHEMBL8896382 | 0.84 | LMNA (0.65) | LMNATSHRSMN1; SMN2CYP3A4ALDH1A1 | |
| SCHEMBL8370097 | 0.84 | LMNA (0.65) | LMNATSHRSMN1; SMN2CYP3A4ALDH1A1 | |
| SCHEMBL15482182 | 0.84 | LMNA (0.51) | LMNATSHRSMN1; SMN2CYP3A4ALDH1A1 | |
| Thiamphenicol SCHEMBL34635 | 0.82 | LMNA (1.00) | LMNATSHRSMN1; SMN2CYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8232265-B2 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-07-31 | — | — | US | disclosed |
| US-8158372-B2 | Agonists of a bitter taste receptor and uses thereof | DEUTSCHES INSTITUT FÜR ERNÄHRUNGSFORSCHUNG POTSDAM-REHBRÜCKE (DE) | 2012-04-17 | — | — | US | disclosed |
| US-20110166359-A1 | PROCESS FOR PREPARING OXAZOLINE-PROTECTED AMINODIOL COMPOUNDS USEFUL AS INTERMEDIATES TO FLORFENICOL | INTERVET INTERNATIONAL B.V. (NL) | 2011-07-07 | — | — | US | disclosed |
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | SLC5A6, PNLIP, IPMK | LMNA 1556/4885TSHR 4253/4885SMN1; SMN2 742/4885 |
| US-20110166359-A1 | PROCESS FOR PREPARING OXAZOLINE-PROTECTED AMINODIOL COMPOUNDS USEFUL AS INTERMEDIATES TO FLORFENICOL | PFAS, DHFR, OXA1L | LMNA 1876/4885TSHR 4330/4885SMN1; SMN2 1703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.